$HUM

Humana partners with BlackRock in $2.8B CenterWell clinic deal

Humana HUM has partnered with BlackRock BLK to manage 150 CenterWell clinics, replacing a prior joint venture. BlackRock will acquire a $2.8B stake, with the new venture majority-owned by BlackRock. Humana expects reduced liabilities and improved financial flexibility. The deal is expected to close in Q4 2023 and will not materially affect Humana's 2026 earnings guidance.

Original reporting
Published Oct 13, 2026, 10:43 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 11:24 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Humana partners with BlackRock in $2.8B CenterWell clinic deal — source image
Decision brief

The 30-second read

$HUMBullishHigh
01

Why it matters

The partnership aims to reduce Humana’s liabilities and give BlackRock a foothold in health‑care operations, potentially improving earnings visibility for both.

02

Market read

First‑report of a $2.8 B health‑care joint venture that could shift balance‑sheet dynamics for Humana and expand BlackRock’s asset portfolio.

03

What to watch

Regulatory approval risk for the joint venture and integration challenges may delay expected benefits.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Humana and BlackRock are forming a new joint venture to manage 150 CenterWell primary‑care clinics, with BlackRock buying the existing private‑equity partner’s stake.

Company-level read

Ticker impact

$HUMBullishHigh confidence
Context

Humana announced a $2.8 B joint‑venture with BlackRock to take over CenterWell clinics, a fresh deal that could lower liabilities and cost of capital.

Expected impact

likely modest upside as investors price in lower liabilities and improved flexibility

Evidence & confidence

First‑report of a large‑scale partnership; market already nudged the stock higher pre‑market.

$BLKBullishHigh confidence
Context

BlackRock will acquire WCAS’s equity stake in CenterWell clinics for roughly $2.8 B, becoming majority owner of the new joint venture.

Expected impact

neutral to slight upside as the acquisition fits BlackRock’s diversification strategy

Evidence & confidence

First‑report of a material acquisition; investors may view it as strategic expansion.

Market effects

Healthcare services sector may see consolidation pressure; asset managers gain exposure to clinic operations.

U.S. health‑care and financial services stocks could see modest ripple effects.

Limited to U.S. markets; no immediate global macro impact.

Counterpoint

The deal could strain BlackRock’s balance sheet if clinic performance underperforms, weighing on the stock.

Key entities

  • Humana

    U.S. health‑insurance provider (ticker HUM).

  • BlackRock

    World’s largest asset manager (ticker BLK).

  • CenterWell

    Operator of senior primary‑care clinics (private).

Related articles

Med

Humana AB (HUM) To Be Delisted From Nasdaq Stockholm

Humana AB (HUM) will be delisted from Nasdaq Stockholm, with the last trading day set for 27 October 2026. The decision was made by Nasdaq Stockholm, according to the company. The impact on valuation will depend on further details, such as reasons for delisting and post-delist trading options.

$HUMHighAI 9/10

BlackRock Will Manage Humana’s CenterWell Clinics In New $2.8 Billion Partnership

Humana has partnered with BlackRock's HPS Investment Partners to manage its CenterWell primary care clinics, replacing a previous deal with WCAS. BlackRock will acquire WCAS's stake, valued at $2.8 billion. The joint venture plans to expand the clinic network and fund operations, with CenterWell continuing management. Humana aims to grow its healthcare services business, with the new venture majority-owned by BlackRock and minority-owned by CenterWell.

$HUMMed

Humana Brings BlackRock In To Run 150 CenterWell Clinics

Humana has partnered with BlackRock to manage 150 CenterWell clinics, with an option for CenterWell to repurchase them by 2033. The deal removes 'put arrangements' that Humana says will reduce balance-sheet liabilities and potentially lower borrowing costs. The transaction is expected to close in Q4 2023 and will not materially impact 2026 adjusted earnings. Humana aims to improve financial flexibility and manage risk more effectively.

$HUMMed

Humana Announces New Strategic Joint Venture with BlackRock to M

Humana (HUM) has formed a joint venture with BlackRock to manage 150 CenterWell clinics, replacing existing partnerships. BlackRock will acquire WCAS's stake, valued at $2.8B, and invest in expansion. The deal, expected to close in Q4 2026, reduces Humana's balance sheet liabilities and lowers its cost of capital. Humana's 2026 earnings guidance remains unchanged.